Letters and drug alerts sent to healthcare professionals in July 2018

Letters were sent about valproate medicines, atezolizumab (Tecentriq▼), and nusinersen (Spinraza▼). MHRA issued alerts and recalls for valsartan-containing medicines, Fiasp FlexTouch pre-filled pens, melatonin capsules, and sodium cromoglicate eye drops.

In July 2018, the following letters were sent from licence holders to healthcare professionals about the safety of medicines:

In July 2018, MHRA issued the following Alerts and recalls for drugs:

Please continue to submit your thoughts on how we can improve the communication of medicines safety issues to support safe and effective use through this 10-minute survey.

Article citation: Drug Safety Update volume 12, issue 1; August 2018: 2.

Published 24 August 2018